While the government has declared that the Foreign Investment Promotion Board will be the gatekeeper for clearing foreign investments in Indian pharmaceutical companies, amendments to the Competition Act to explicitly provide legislation for the FIPB’s new authority have not yet been finalized. The government has said that the FIPB will review any proposals for foreign investment until those amendments to the Competition Act have been made. The strategy is part of an effort to ensure affordable prescription prices. While all foreign investment was initially permitted automatically, meaning that investors did not need government clearance, Prime Minister Manmohan Singh had attempted to remedy the situation by suggesting all foreign investment proposals first go to the FIPB for six months and then to the Competition Commission of India; upon discovery that the CCI did not hold this jurisdiction, all foreign direct investment deals were put on hold. While deal clearances have begun again, a source says the plan is to ensure the manufacturing of essential drugs by those who acquire Indian firms until the CCI is allowed to review the acquisition after amendments have been made.
Full Content: The Times of India
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI